CLINICAL_TRIALS
trial_result
· 2022-02-18
Clinical Trial Update: Study of Sargramostim in Patients With COVID-19 [Phase 2]
Summary
Phase 2 clinical trial of sargramostim in COVID-19 patients has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Partner Therapeutics, Inc. | Conditions: COVID-19, SARS-CoV-2 | Phase 2 | Status: COMPLETED | Results posted: 2022-02-18